• The effect of sphingosine‐1‐phosphate on the endothelial glycocalyx during ischemia‐reperfusion injury in the isolated rat heart 

  Araibi, Hala; van der Merwe, Elizabeth; Gwanyanya, Asfree; Kelly‐Laubscher, Roisin (John Wiley & Sons, Inc., 2020-02-03)

  Objective: Sphingosine‐1‐phosphate is a natural metabolite that is cardioprotective, but its effects on endothelial glycocalyx damage during ischemia‐reperfusion are unknown. Therefore, we investigated the effect of ...
• Bone regenerative potential of the selective sphingosine 1-phosphate receptor modulator siponimod: In vitro characterisation using osteoblast and endothelial cells 

  Sartawi, Zaid; Ryan, Katie B.; Waeber, Christian (Elsevier B.V., 2020-06-10)

  The repair of critical bone defects remains a significant therapeutic challenge. While the implantation of drug-eluting scaffolds is an option, a drug with the optimal pharmacological properties has not yet been identified. ...
• Investigating mitochondrial dysfunction in gestational diabetes mellitus and elucidating if BMI is a causative mediator 

  McElwain, Colm; McCarthy, Cathal M. (Elsevier B.V., 2020-05-21)

  Objective: Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance which is diagnosed during pregnancy and poses considerable health risks for mother and child. Maternal body mass index (BMI) ...
• A study of magnesium stearate behaviour in pharmaceutical blends and tablets employing Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) 

  Peddapatla, Raghu V. G. (University College Cork, 2019)

  Magnesium Stearate (MgSt) is the most commonly used lubricant in pharmaceutical industries. Effects of MgSt on the final product have been extensively studied in batch processing. In recent times pharmaceutical companies ...
• The virtually mature BNP (BNP1-32) is a precursor for the more effective BNP1-30 

  Schwiebs, Anja; Wang, Yong; Moore, Andrew M.; Zhu, Xudong; Pankow, Kristin; Siems, Wolf-Eberhard; Walther, Thomas (John Wiley & Sons, Inc., 2019-11-06)

  Background and Purpose: The B‐type natriuretic peptide (BNP1‐32) exerts vasorelaxing and cardioprotective activity. BNP is used as a biomarker for the diagnosis of cardiopathological conditions and recombinant BNP1‐32 as ...

View more